Cardiopatch MISSION

CARDIOPACTH mission is to contribute to minimize the negative impacts that CVD, in particular Myocardial Infarction has in the South-West Europe regions by designing and developing a novel advanced therapy for its treatment based on Regenerative Medicine and 3D printing.

In parallel, the project seeks to generate new strategic synergies between key actors from the Health and 3D printing sectors: enterprises, hospitals, labs, research institutions, universities and public authorities.


Cardiopatch VISION

CARDIOPACTH vision is to become the First Network of Excellence that promotes R&D in Cardiac Regenerative Medicine (CRM) and 3D printing applied to MI treatment in the Southwest Europe regions with a four-fold approach:

Cardiopatch VALUES

CARDIOPACTH values describe the work philosophy of its founder’ members and reflect the joint vision and mission statements. Our values are:

Inspiring & Dynamic

We inspire key actors from the Health and 3D printing sectors (enterprises, hospitals, labs, research institutions, universities and public authorities) to work together by facilitating tools to help them to identify potential work synergies, cooperation opportunities, funding sources, knowledge sharing and exchange of experiences.


We cultivate openness, transparency and interaction together with the stakeholders that we serve. We support the development of future innovations in Cardiac Regenerative Medicine, and we believe in sharing knowledge and co-creating with our stakeholders.


We are passionate about bringing and promoting the potentialities that 3D printing has in the Health sector while we contribute to advance in field of the Cardiac Regenerative Medicine applied to Myocardial Infarction.


We are committed and results-oriented when we engage with our stakeholders – we accelerate processes and work with our stakeholders to make synergies a reality.


We strive to achieve excellence in our work through our professional, efficient and results-orientated approach.